HIGHLIGHTS
- who: Alyson Haslam from the University of California San Francisco, , th St, nd Fl, CA , San Francisco, USA have published the article: Umbrella review of basket trials testing a drug in tumors with actionable genetic biomarkers, in the Journal: (JOURNAL) of March/16,/2022
- what: We found that while there has been an increase in the number of published basket trials and individuals included in these trials, little progress has been made on increasing the number of participants with rare tumor types, and response rates vary widely, depending on tumor type and genetic biomarker.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.